The Role of Lipidogram Parameters during Pregnancy in the Prediction of Preeclampsia Development

Abstract

Aim of investigation. To study the correlation between lipid metabolism during pregnancy and the risk of preeclampsia (PE). Material and methods. We have studied parameters of lipid metabolism in the blood serum of 267 pregnant women with the help of diagnostic kits. Blood sampling was carried out in I and II gestation trimesters. Total cholesterol (TC) and triglycerides (TG) were determined by colorimetric, enzymatic methods; high density lipoproteins (HDL) — ​with homogeneous method, low density lipoproteins (LDL) — ​with the direct method. Very low density lipoproteins (VLDL) concentration was calculated from the Friedwald equation: VLDL = TG / 2.2. Depending on the clinical picture of PE, 43 pregnant women were divided into groups with mild and moderate-to-severe courses of the disease. Results. Among women with PE, we observed significant changes of the lipid profile parameters in the II trimester. These women had elevated TG levels in the blood serum: I group — ​1.73 ± 0.14 mM/l, II group — ​1.86 ± 0.18 mM/l as compared to the group III (controls) — ​1.32 ± 0.29 mM/l; decreased HDL indices: I group — ​0.79 ± 0.19 mM/l; group II — ​0.64 ± 0.04 mM/l in comparison with the control group — ​1.17 ± 0.12 mM/l and increased VLDL — ​0.78 ± 0.09 mM/l for group I, 0.90 ± 0.06 mM/l in women of group II unlike group III — ​0.60 ± 0.16 mM/l. TC and LDL levels among patients with PE did not differ from pregnant women in the control group. Conclusions. It was demonstrated the existence of an imbalance in the synthesis of lipoproteins in women, whose pregnancies were complicated by development of PE that manifested by hypertriglyceridemia with predominance of atherogenic fractions. It was found that the investigation of the parameters of lipid profile in the II trimester of pregnancy allows us to predict the risk of PE and its long-term cardiovascular and metabolic consequences.

Authors and Affiliations

I. B. Ventskovskaya, А. V. Аksionova, Т. Y. Yuzvenko

Keywords

Related Articles

Effect of Combination Treatment for Hypothyroidism on Renal Function in Patients with Hypothyroidism

Objective. To improve known methods of diagnosing kidney damage in patients suffering from hypothyroidism with elements of metabolic syndrome, to study the effect of combined treatment on renal function. Materials and me...

Morphometric and Biochemical Clusters of Metabolic Syndrome in Type 2 Diabetic Patients at Different Stages of Diabetic Retinopathy

Background. We studied the morphometric and biochemical clusters of metabolic syndrome in patients with type 2 diabetes mellitus (DM) at different stages of diabetic retinopathy (DR). Materials and methods. The study inc...

Polycystic Ovary Syndrome: Laboratory Diagnosis of Hyperandrogenic Status of a Woman (A Review of the Article «The Polycystic Ovary Syndrome: a Position Statement from the European Society of Endocrinology», October 2014)

The article presents the modern laboratory aspects for evaluation of hyperandrogenism according to published in October 2014 document of the European Society of Endocrinology in the diagnosis and treatment of polycystic...

Nuances of insulin therapy in the treatment of the diabetic ketoacidosis

Background. The well-defined program of the insulin therapy is a guarantee of efficient treatment of a patient with the diabetic ketoacidosis. The approaches to the treatment varied depending on the gained experience, ho...

Laboratory Diagnosis of Some Components of Metabolic Syndrome

Metabolic syndrome is a complex of interrelated risk factors for cardiovascular diseases and diabetes mellitus. The prevalence of metabolic syndrome grows progressively all over the world due to the increased number of p...

Download PDF file
  • EP ID EP200175
  • DOI 10.22141/2224-0721.5.77.2016.78754
  • Views 63
  • Downloads 0

How To Cite

I. B. Ventskovskaya, А. V. Аksionova, Т. Y. Yuzvenko (2016). The Role of Lipidogram Parameters during Pregnancy in the Prediction of Preeclampsia Development. Міжнародний ендокринологічний журнал, 5(77), 51-55. https://europub.co.uk/articles/-A-200175